杨志云，首都医科大学附属北京地坛医院中西医结合中心主任医师，教授，博导，科教处处长。北京市卫生系统高层次人才，第六批全国老中医药专家学术经验继承人。从事中西医结合肝病诊疗与研究20余年，在中西医结合治疗肝癌、肝硬化及并发症、病毒性肝炎、脂肪性肝病等方面有丰富经验。主要研究方向中西医结合治疗肝癌、肝硬化及并发症、病毒性肝炎、脂肪性肝病等方面有丰富经验。社会任职北京中西医结合肝病学会秘书长中国医师协会中西医结合肝病学会常委获奖荣誉省部级以上奖项3项科研成果近5年承担国家及北京市自然基金3项。发表SCI论文18篇。授权发明专利1项。发表代表论文及著作：1.ZhiyunYang,LiWang,YixinHou,XianboWang.Effectsofmatrineonovalcell-mediatedliverregenerationandofRBP-JκandHES1[J].MolecularMedicineReports,2013,7(5):1533-15382.LinglingHe,XiaoliLiu,LijiaWang,ZhiyunYang.Thiazolidinedionesfornonalcoholicsteatohepatitis:Ameta-analysisofrandomizedclinicaltrials[J].Medicine,2016,95(42):e49473.XiaoliLiu,LinglingHe,JunyanHan,LijiaWang,MenggeLi,YuyongJiang,XianboWang,ZhiyunYang.Associationofneutrophil-lymphocyteratioandTlymphocyteswiththepathogenesisandprogressionofHBV-associatedprimarylivercancer[J].PLoSOne,2017,12(2):e01706054.LinglingHe,ShuanZhang,XiaoliLiu,YuyongJiang,XianboWang,ZhiyunYang.HbA1c-basedscoremodelforpredictingdeathriskinpatientswithHepatocellularCarcinomaandType2DiabetesMellitus[J].JournalofDiabetesResearch,2017,2017:38195025.LinglingHe,XiaoliLiu,YalinZhao,ShuanZhang,YuyongJiang,XianboWang,ZhiyunYang.Efficacyofnucleot(s)ideanalogstherapyinpatientswithunresectableHBV-relatedhepatocellularcarcinoma:asystematicreviewandmeta-analysis[J].DiseaseMarkers,2017,ID70759356.ShuanZhang,LinglingHe,XinhuiWang,ZhiboDang,XiaoliLiu,MenggeLi,XianboWang,ZhiyunYang,ANovelScoringmodelforpredictingmortalityriskinpatientswithcirrhosisandhepatorenalsyndrome[J].EuropeanJournalofGastroenterologyandHepatology,2018,30(8):938-943.7.XiaoliLiu,MenggeLi,XinhuiWang,ZhiboDang,YuyongJiang,XianboWang,ZhiyunYang.Effectofserumtriglyceridelevelontheprognosisofpatientswithhepatocellularcarcinomaintheabsenceofcirrhosis[J].Lipidsinhealthanddisease,2018,17(1):248.8.ZhiboDang,XiaoliLiu,MenggeLi,XinhuiWang,YuyongJiang,XianboWang,ZhiyunYang,ComparativeeffectivenessandsafetyoftraditionalChinesemedicinesupportingQiandenrichingbloodforcancerrelatedanemiainpatientsnotreceivingchemoradiotherapy:ameta-analysisandsystematicreview[J].DrugDesign,DevelopmentandTherapy,2019,13:221.9.LinglingHe,XiaoliLiu,ShuanZhang,MenggeLi,XianboWang,YuyongJiang,ZhiyunYang,Independentriskfactorsforpostoperative1-yearrecurrenceinpatientswithHBV-relatedhepatocellularcarcinoma≤3cm,GastroenterologyReport,accepted.10.XinhuiWang,XiaoliLiu,ZhiboDang,LihuaYu,YuyongJiang,XianboWang,ZhiyunYang*,Nucleos(t)ideanaloguesforreducinghepatocellularcarcinomainchronichepatitisBpatients:Asystematicreviewandmeta-analysis,GutandLiver,accepted.11.XiaoliLiu,MenggeLi,XinhuiWang,ZhiboDang,LihuaYu,XianboWang,YuyongJiang,ZhiyunYang*,EffectsofAdjuvantTraditionalChineseMedicineTherapyonLong-termSurvivalinPatientswithHepatocellularCarcinoma,Phytomedicine，accepted.承担科研项目情况1.国家自然科学基金项目《苦参碱与肝卵圆细胞移植协同治疗急性肝衰竭的实验研究》（编号：30873423）。2.国家自然科学基金项目《养阴扶正解毒方逆转T细胞功能耗竭治疗乙肝相关原发性肝癌的机制研究》（编号：81874435）。3.北京市自然科学基金项目《WNT信号通路在慢性乙型肝炎肝纤维化进程中作用及凉血解毒方干预机制研究》（编号：7142081）。4.北京市科学技术委员会“首都临床特色应用研究”重点项目《基于综合预警模型筛选养阴扶正解毒法降低小肝癌微创术后复发率的优势人群临床研究》（编号：Z171100001017082）。获得专利及成果专利名称:用CD8阳性的T细胞上PD-1和TIGIT确定HBV相关原发性肝癌预后的系统专利号：201711436077.3...擅长：中西医结合肝病基础与临床研究（中西医结合诱导肝干细胞分化修复肝损伤）。主治病种：各种急性病毒性肝炎、慢性乙型肝炎、慢性丙型肝炎、自身免疫性肝炎、药物性肝炎、酒精性肝炎、脂肪肝、肝炎肝硬化、原发性肝癌等